Non-Hodgkin Lymphoma News

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature

Primary Diffuse Large B-cell Lymphoma of the Urinary Bladder: A Case Report and Narrative Review of Treatment Modalities and Clinical Outcomes - Cureus

Primary Diffuse Large B-cell Lymphoma of the Urinary Bladder: A Case Report and Narrative Review of Treatment Modalities and Clinical Outcomes Cureus

Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com

Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com

Study reveals promising new therapy for non-Hodgkin lymphoma - Medical Xpress

Study reveals promising new therapy for non-Hodgkin lymphoma Medical Xpress

Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL - The ASCO Post

Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL The ASCO Post

Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers

Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers

Primary pancreatic non-Hodgkin lymphoma (with... : Endoscopic Ultrasound - Ovid

Primary pancreatic non-Hodgkin lymphoma (with... : Endoscopic Ultrasound Ovid

7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore - Hartford HealthCare

7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore Hartford HealthCare

National Poetry Month: "Non-Hodgkin’s Lymphoma" - The Rumpus

National Poetry Month: "Non-Hodgkin’s Lymphoma" The Rumpus

Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch

Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch

New long-term analysis suggests follicular lymphoma can be cured - Fred Hutchinson Cancer Center

New long-term analysis suggests follicular lymphoma can be cured Fred Hutchinson Cancer Center

Advances in lymphoma treatment: new therapies and clinical trials - Penn Medicine

Advances in lymphoma treatment: new therapies and clinical trials Penn Medicine

Dr Morillo on Future Directions for Golcadomide in R/R Follicular Lymphoma - OncLive

Dr Morillo on Future Directions for Golcadomide in R/R Follicular Lymphoma OncLive

Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature

Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature

Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs - Cureus

Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs Cureus

Non-Hodgkin’s lymphoma presenting as a retroperitoneal mass in the emergency department: a case report - Frontiers

Non-Hodgkin’s lymphoma presenting as a retroperitoneal mass in the emergency department: a case report Frontiers

Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review - Frontiers

Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review Frontiers

Ureteral Involvement in Non-Hodgkin Lymphoma: A Rare Case Report With Diagnostic Challenges - Cureus

Ureteral Involvement in Non-Hodgkin Lymphoma: A Rare Case Report With Diagnostic Challenges Cureus

Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma | Signal Transduction and Targete - Nature

Long-term follow-up demonstrates the curative potential of dual CD19/CD22 CAR-T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma | Signal Transduction and Targete Nature

Diagnostic Uncertainty in Rapidly Progressive Brainstem Lesions: A Radiological Diagnosis of Probable CNS Relapse of Diffuse Large B-cell Lymphoma - Cureus

Diagnostic Uncertainty in Rapidly Progressive Brainstem Lesions: A Radiological Diagnosis of Probable CNS Relapse of Diffuse Large B-cell Lymphoma Cureus

Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report - Frontiers

Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report Frontiers

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma - Nature

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma Nature

Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report - Frontiers

Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report Frontiers

Non-Hodgkin lymphoma survivor thankful for clinical trial - UT MD Anderson

Non-Hodgkin lymphoma survivor thankful for clinical trial UT MD Anderson

Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature - Frontiers

Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers

A Rare Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in a Transgender Patient With Exclusive Smooth Implant Exposure - Cureus

A Rare Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in a Transgender Patient With Exclusive Smooth Implant Exposure Cureus

Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin - UT MD Anderson

Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin UT MD Anderson

Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN

Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN

CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight - Yahoo Finance

CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight Yahoo Finance

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial - Nature

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial Nature

Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Wiley & Sons

Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Wiley & Sons

Current treatment algorithm: diffuse large B cell lymphoma - Blood Cancer Journal - Nature

Current treatment algorithm: diffuse large B cell lymphoma - Blood Cancer Journal Nature

In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas - OncLive

In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas OncLive

Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription - Nature

Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription Nature

CAR-NK Shows Long-Term Response in Waldenström Non-Hodgkin Lymphoma - Cure Today

CAR-NK Shows Long-Term Response in Waldenström Non-Hodgkin Lymphoma Cure Today

U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings - AboutLawsuits.com

U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings AboutLawsuits.com

Case Report: A case of jejunal T-cell non-Hodgkin lymphoma with secondary bone involvement presenting as gastrointestinal perforation - Frontiers

Case Report: A case of jejunal T-cell non-Hodgkin lymphoma with secondary bone involvement presenting as gastrointestinal perforation Frontiers